Merck & Co., Inc.MRKNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P3
Near historical low
vs 5Y Ago
-1.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -100.00% |
| Q3 2025 | 137.53% |
| Q2 2025 | 31.72% |
| Q1 2025 | -27.54% |
| Q4 2024 | -62.87% |
| Q3 2024 | 64.82% |
| Q2 2024 | 82.43% |
| Q1 2024 | 1156.10% |
| Q4 2023 | -96.81% |
| Q3 2023 | 108.34% |
| Q2 2023 | 176.62% |
| Q1 2023 | -69.77% |
| Q4 2022 | -20.92% |
| Q3 2022 | 30.22% |
| Q2 2022 | -9.64% |
| Q1 2022 | -5.37% |
| Q4 2021 | 4.88% |
| Q3 2021 | 92.65% |
| Q2 2021 | 39.03% |
| Q1 2021 | -55.29% |
| Q4 2020 | 84.35% |
| Q3 2020 | -35.46% |
| Q2 2020 | 376.24% |
| Q1 2020 | -85.25% |
| Q4 2019 | 13.44% |
| Q3 2019 | 37.03% |
| Q2 2019 | 130.84% |
| Q1 2019 | -62.81% |
| Q4 2018 | 28.61% |
| Q3 2018 | -17.42% |
| Q2 2018 | 192.81% |
| Q1 2018 | -71.23% |
| Q4 2017 | 442.87% |
| Q3 2017 | -135.30% |
| Q2 2017 | 1059.79% |
| Q1 2017 | -92.13% |
| Q4 2016 | 22.25% |
| Q3 2016 | 83.96% |
| Q2 2016 | -25.16% |
| Q1 2016 | -49.19% |